Prostate-specific Membrane Antigen Positron Emission Tomography-detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective StudyEUROPEAN UROLOGYIF25.22024-06-012OA
Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on EnzalutamideCLINICAL CANCER RESEARCHIF10.22024-01-167PRE
The Biocartis Idylla GeneFusion Assay (RUO) for lung cancer testing: The experience of testing over 5000 tumours in routine practiceANNALS OF ONCOLOGYIF65.42023-10-010PRE
Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by Prostate-specific Antigen Doubling Time: Planned Subgroup Analysis of the Phase 3 ARAMIS Trial (vol 83, pg 212, 2023)EUROPEAN UROLOGYIF25.22023-02-011OA
Multicenter Evaluation of the Idylla GeneFusion in Non-Small-Cell Lung CancerJOURNAL OF MOLECULAR DIAGNOSTICSIF3.42022-09-0113OAAI
Predictive markers for anti-PD-1/PD-L1 therapy in non-small cell lung cancer-where are we?TRANSLATIONAL LUNG CANCER RESEARCHIF3.52018-12-0126OAAI
Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal CancerJOURNAL OF MOLECULAR DIAGNOSTICSIF3.42018-09-0119OAAI
Microscopic gastrointestinal stromal tumours: a clinical and molecular study of 13 casesHISTOPATHOLOGYIF4.12016-10-248PREAI
Mechanisms of resistance to immuno and targeted therapies in acral melanomaCANCER RESEARCHIF16.62016-07-151PRE